Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Colorcon
Mallinckrodt
Dow
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,486,456

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,486,456 protect, and when does it expire?

Patent 8,486,456 protects ONMEL and is included in one NDA.

This patent has eight patent family members in five countries.

Summary for Patent: 8,486,456
Title:Itraconazole compositions with improved bioavailability
Abstract: A solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose, which satisfies the Formula 0.35>.DELTA.H.sub.tr (1) (wherein .DELTA.H.sub.tr represents the endotherm (J/g) accompanying a transition at about 240.degree. C). The solid dispersion product shows an improved bioavailability.
Inventor(s): Berndl; Gunther (Herheim am Berg, DE), Degenhardt; Matthias (Limburgerhof, DE), Maegerlein; Markus (Mannheim, DE), Dispersyn; Gerrit (Pennington, NJ)
Assignee: Abbott GmbH & Co., KG (Wiesbaden, DE)
Application Number:11/997,256
Patent Claim Types:
see list of patent claims
Compound; Formulation; Dosage form; Use;

Drugs Protected by US Patent 8,486,456

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Ireland Ltd ONMEL itraconazole TABLET;ORAL 022484-001 Apr 29, 2010 RX Yes Yes   Start Trial   Start Trial Y ONYCHOMYCOSIS OF THE TOENAIL CAUSED BY TRICOPHYTON RUBRUM OR TRICHOPHYTON MENTAGROPHYTES, ONCE DAILY USE FOR 12 CONSECUTIVE WEEKS   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,486,456

PCT Information
PCT FiledAugust 08, 2006PCT Application Number:PCT/EP2006/007839
PCT Publication Date:February 15, 2007PCT Publication Number: WO2007/017248

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
Merck
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.